Valiglurax
Valiglurax (VU2957), also known as VU0652957 and VU2957, is a potent, selective, CNS penetrant, and orally bioavailable mGlu4 PAM. VU2957 possessed attractive in vitro and in vivo pharmacological and DMPK properties across species. VU2957 was evaluated as a preclinical development candidate for the treatment of Parkinson’s disease.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
329.28
Molecular Formula
C16H10F3N5
Notes
Research use only, not for human use.
Receptor
GluR
CAS Number
1976050-09-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1055192-01 5 g
Rel- (1S,1'r,4R,4'R) -4-propyl-4'- (4-propylphenyl) -1,1'-bi (cyclohexane)
Ask
View Details 
OR1055192-02 25 g
Rel- (1S,1'r,4R,4'R) -4-propyl-4'- (4-propylphenyl) -1,1'-bi (cyclohexane)
Ask
View Details 
OR1055192-03 100 g
Rel- (1S,1'r,4R,4'R) -4-propyl-4'- (4-propylphenyl) -1,1'-bi (cyclohexane)
Ask
View Details RC214654L3V 200 µL
Tankyrase 2 (TNKS2) (NM_025235) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details